Fetal valproate spectrum disorder

Fetal valproate spectrum disorder (FVSD), previously known as Fetal Valproate Syndrome (FVS), is a rare disease caused by prenatal exposure to valproic acid (VPA), a medication commonly used to treat epilepsy, bipolar disorder, and migraines. This exposure can lead to a range of neurodevelopmental and physical symptoms, including cognitive impairments, developmental delays, autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and congenital malformations.